Gene · 64115
Papers2,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential therapies targeting nuclear metabolic regulation in cancer. | MedComm (2020) | 2023 | 38034101 | PubTator, text mining | PubMed |
| The cross-talk between macrophages and tumor cells as a target for cancer treatment. | Front Oncol | 2023 | 38033495 | PubTator, text mining | PubMed |
| Reprogramming Cancer Cells to Antigen-presenting Cells. | Bio Protoc | 2023 | 38023788 | PubTator, text mining | PubMed |
| Cholesterol in colorectal cancer: an essential but tumorigenic precursor? | Front Oncol | 2023 | 38023258 | PubTator, text mining | PubMed |
| TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines. | Front Immunol | 2023 | 38022614 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia. | Front Immunol | 2023 | 38022588 | PubTator, text mining | PubMed |
| Decellularized diseased tissues: current state-of-the-art and future directions. | MedComm (2020) | 2023 | 38020712 | PubTator, text mining | PubMed |
| Emerging trends in clinical cancer genomic research. | Cancer Biol Med | 2023 | 38018030 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors for multiple myeloma immunotherapy. | Exp Hematol Oncol | 2023 | 38017516 | PubTator, text mining | PubMed |
| Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy. | Signal Transduct Target Ther | 2023 | 38016957 | PubTator, text mining | PubMed |
| In vitro co-culture studies and the crucial role of fibroblast-immune cell crosstalk in IPF pathogenesis. | Respir Res | 2023 | 38012580 | PubTator, text mining | PubMed |
| Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines. | Vaccines (Basel) | 2023 | 38005965 | PubTator, text mining | PubMed |
| ZNF643/ZFP69B Exerts Oncogenic Properties and Associates with Cell Adhesion and Immune Processes. | Int J Mol Sci | 2023 | 38003570 | PubTator, text mining | PubMed |
| Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches. | Cancers (Basel) | 2023 | 38001644 | PubTator, text mining | PubMed |
| Joint epigenome profiling reveals cell-type-specific gene regulatory programmes in human cortical organoids. | Nat Cell Biol | 2023 | 37996647 | PubTator, text mining | PubMed |
| Expression of Galectin-9-related immune checkpoint receptors in B-cell acute lymphoblastic leukemia. | Iran J Basic Med Sci | 2023 | 37970435 | PubTator, text mining | PubMed |
| Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy. | Acta Pharm Sin B | 2023 | 37969728 | PubTator, text mining | PubMed |
| Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers. | Front Oncol | 2023 | 37965456 | PubTator, text mining | PubMed |
| Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer. | Front Immunol | 2023 | 37965307 | PubTator, text mining | PubMed |
| Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy. | Proc Natl Acad Sci U S A | 2023 | 37963244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64115/papers?page=18